Tumor immunotherapy is only effective in a fraction of patients due to a low response rate
and severe side effects, and these challenges of immunotherapy in clinics can be addressed …

Cancer immunotherapy (CIT) has gained increasing attention and made promising progress
in recent years, especially immune checkpoint inhibitors such as antibodies blocking …

Oxaliplatin was the third Pt-based anticancer drug to be clinically used worldwide. It exhibits
a broad spectrum of anticancer activity and was the first to be approved for the treatment of …

Advanced liver cancer is the most fatal malignant cancer, and the clinical outcomes of
treatment are not very satisfactory due to the complexity and heterogeneity of the tumor …

Due to the specific advantages of ultrasound (US) in therapeutic disease treatments, the
unique therapeutic US technology has emerged. In addition to featuring a low‐invasive …

Microbubbles are 1–10 μm diameter gas-filled acoustically-active particles, typically
stabilized by a phospholipid monolayer shell. Microbubbles can be engineered through …

Background Large-dose melatonin treatment in animal experiments was hardly translated
into humans, which may explain the dilemma that the protective effects against myocardial …

Sonochemistry, although established in various fields, is still an emerging field finding new
effects of ultrasound on chemical systems and are of particular interest for the biomedical …

Triple-negative breast cancer (TNBC) is a special subtype of breast cancer, which is highly
aggressive and incurable. Here, we proposed an ultrasound activatable bromodomain …

Purpose Ultrasound nanobubbles (NBs) can kill tumor cells, mediated by their effects of
cavitation and acoustic perforation through ultrasound, while as novel drug carriers …